Prescribing bevacizumab off-label contravenes GMC advice

BMJ. 2011 Nov 8:343:d7131. doi: 10.1136/bmj.d7131.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / economics*
  • Antibodies, Monoclonal / economics*
  • Antibodies, Monoclonal, Humanized / economics*
  • Bevacizumab
  • Humans
  • Ranibizumab
  • Wet Macular Degeneration / economics*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Ranibizumab